Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Ivan Krečak"'
Autor:
Ivan Krečak, Josipa Antonija Bačić, Nevena Šimunić, Vesna Bušac, Ljerka Pivac, Eva Čubrić, Marko Skelin, Marko Lucijanić
Publikováno v:
Heliyon, Vol 10, Iss 12, Pp e32827- (2024)
The presence of steatotic liver disease (SLD) is associated with an increased cardiovascular risk in the general population. Chronic myeloproliferative neoplasms (MPNs), essential thrombocythemia (ET) and polycythemia vera (PV), are characterized by
Externí odkaz:
https://doaj.org/article/9e831ce998004f139572cabd7289c77c
Autor:
Ivan Krečak, Velka Gverić-Krečak
Publikováno v:
Acta Clinica Croatica, Vol 62., Iss 2, Pp 382-385 (2023)
Despite being extremely rare, Guillain-Barré syndrome (GBS) has been recognized as a neurological complication of multiple myeloma, with variable responses to plasmapheresis (PEX), intravenous immunoglobulins (IVIG), and anti-myeloma therapies. In
Externí odkaz:
https://doaj.org/article/3456817303c44e5d9af0a7e9fb5d6035
Autor:
Eva Čubrić, Matilda Kinkela, Anamarija Stipaničev, Ivana Skorić, Iris Kušpilić Papak, Ivan Krečak
Publikováno v:
Liječnički vjesnik, Vol 145, Iss 1-2, Pp 55-57 (2023)
Externí odkaz:
https://doaj.org/article/5cd100e2554442e58f859b9243889577
Autor:
Ivan Krečak, Pavle Rončević, Marin Kursar, Marko Lucijanić, Davor Galušić, Stefan Mrđenović, Martina Morić Perić, Iva Ivanko, Hana Matijaca, Josipa Budimir, Sanja Jakelić, Ivana Karaman, Rajko Kušec
Publikováno v:
Liječnički vjesnik, Vol 144, Iss 9-10, Pp 306-313 (2022)
Aim: The aims of this study were to identify patients with systemic mastocytosis (SM) in Croatia and to analyze their clinical characteristics. Patients and methods: Patients with SM treated at eight hospitals in Croatia were retrospectively identifi
Externí odkaz:
https://doaj.org/article/ee897ac6d9ed4b72b3a3c5ccd149951a
Autor:
Igor Aurer, Ozren Jakšić, Sandra Bašić-Kinda, Stefan Mrđenović, Slobodanka Ostojić-Kolonić, Dominik Lozić, Hrvoje Holik, Sabina Novaković-Coha, Petra Berneš, Ivan Krečak, Martina Morić-Perić, Marino Narančić, Zdravko Mitrović, Toni Valković
Publikováno v:
Biomedicines, Vol 12, Iss 2, p 331 (2024)
Patients with lymphoid malignancies are at increased risk of death or prolonged infection due to COVID-19. Data on the influence of different antineoplastic treatment modalities on outcomes are conflicting. Anti-CD20 monoclonal antibodies increase th
Externí odkaz:
https://doaj.org/article/4511e1e613e74b6983e3aef21eb96186
Autor:
Srdan Verstovsek, Ivan Krečak, Florian H. Heidel, Valerio De Stefano, Kenneth Bryan, Mike W. Zuurman, Michael Zaiac, Mara Morelli, Aoife Smyth, Santiago Redondo, Erwan Bigan, Michael Ruhl, Christoph Meier, Magali Beffy, Jean-Jacques Kiladjian
Publikováno v:
Biomedicines, Vol 11, Iss 7, p 1925 (2023)
Patients with polycythemia vera (PV) are at significant risk of thromboembolic events (TE). The PV-AIM study used the Optum® de-identified Electronic Health Record dataset and machine learning to identify markers of TE in a real-world population. Da
Externí odkaz:
https://doaj.org/article/eb02741743d8467e933216cdd1bce442
Autor:
Hrvoje Holik, Ivan Krečak, Marko Lucijanić, Ivan Samardžić, Danijel Pilipac, Ivana Vučinić Ljubičić, Božena Coha, Alma Kitter Pipić, Blaženka Miškić, Silva Zupančić-Šalek
Publikováno v:
Life, Vol 13, Iss 6, p 1388 (2023)
Background: Osteoarthritis (OA) is a progressive degenerative disease with an inflammatory background. Chronic myeloproliferative neoplasms (MPN) are clonal hematopoietic disorders characterized by chronic inflammation and a tendency for connective t
Externí odkaz:
https://doaj.org/article/be95d397d432430eabfcfc704c41c122
Publikováno v:
Biomedicines, Vol 11, Iss 5, p 1301 (2023)
Polypharmacy, potentially inappropriate medications (PIMs), and drug-to-drug interactions (DDIs) are highly prevalent in the elderly and may have adverse effects on health-related outcomes. Their occurrence and clinical and prognostic associations in
Externí odkaz:
https://doaj.org/article/c2bbd5e16d664d72bbe450b55907d207
Publikováno v:
Libri Oncologici, Vol 49, Iss 2-3, Pp 76-79 (2021)
In randomized clinical trials, trifluridine / tipiracil (TT) demonstrated beneficial effects on progression-free survival (PFS) and overall survival (OS) in patients with refractory metastatic colorectal cancer (mCRC). The aim of this unicentric stud
Externí odkaz:
https://doaj.org/article/6662a5908afb425da730166069bc067b
Hematocrit to hemoglobin ratio (HHR) may improve prognostication in patients with pulmonary embolism
Autor:
Ivan Krečak, Monika Čeko, Karla Nižetić, Eva Čubrić, Mediana Županović, Marko Skelin, Marko Lucijanić
Publikováno v:
Scandinavian Journal of Clinical and Laboratory Investigation
Volume 83
Issue 3
Volume 83
Issue 3
Hematocrit to hemoglobin ratio (HHR) may improve prognostication in patients with pulmonary embolism.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b76a25086a5049e71ec725239752f5f5
https://doi.org/10.1080/00365513.2023.2191334
https://doi.org/10.1080/00365513.2023.2191334